Suite d’une injection de substances géniques
Les numéros entre parenthèses correspondent à des études que vous trouverez en fin d'article.
Si vous connaissez d'autres pistes référencés vous pouvez laisser un message détaillé en bas de page.
1.à prendre avant et après l’injection
-Au moins 3 jours avant l’injection prendre du charbon actif
(3 par jour 2 heures avant ou après tout autre médication)
et ne pas en prendre le jour même.
-NAC (N-Acétyl-L-Cystéine) ou du Glutathion liposomal (en continue) (01)
-Quercétine (en continue) (02)
-Vitamine D (en continue) + foie de morue (03)
-Vitamine K2 (en continue)
-Vitamine A (en continue) (04)
-Vitamine C (en continue) (si non présent avec le NAC) (05)
(en continue)
-Vitamine E (en continue) (06)
-Sélénium (en continue)
-Zinc (en continue) + huitres et fruits de mer
-Omega 3
Gemmothérapie :
-Cassis, détoxication, anti allergique,
(3 semaines, arrêt d’une semaine puis reprendre)
-Romarin, hepato-protecteur (3 semaines, arrêt d’une semaine puis reprendre)
-Genévrier, détoxication rein et foie (métaux lourds) (3 semaines, puis attendre 3 mois avant de reprendre)
-Pin sylvestre, détoxication général, protection immunitaire et respiratoire (3 semaines, arrêt d’une semaine puis reprendre)
-Lilas (3 semaines, arrêt d’une semaine puis reprendre)
2.Elimination par les reins et le foie
Artichaud,
Radis noir,
Citron, huile d’olive,
Chardon marie,
Desmodium,
Pissenlit (feuilles)
Hibiscus (feuilles)
Chlorella pyrenoidosa
Charbon actif (pendant 1 semaine)
Persil (jus, tisanes , décoctions)
Grenade
Cresson
Romarin
Prêle
Bétaïne
Acide alpha-lipoïque
Citrate de magnésium
Citrate de potassium
4. Le sang
-Quercétine + Bromélaine (améliore l’absorption de la quercétine) (entre 10 et 200mg/jen prise régulière et 1000mg sur une courte période)
Quercétine organique :
-Capres, Oignons rouges
Références bibliographiques
01. N-Acétyl-L-Cystéine
-De Flora S, Balansky R, La Maestra S. Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19. FASEB J. 2020 Oct;34(10):13185-13193. doi: 10.1096/fj.202001807. Epub 2020 Aug 11. PMID: 32780893; PMCID: PMC7436914.
-Poe FL, Corn J. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2. Med Hypotheses. 2020 Oct;143:109862. doi: 10.1016/j.mehy.2020.109862. Epub 2020 May 30. PMID: 32504923; PMCID: PMC7261085.
-Dinicola S, De Grazia S, Carlomagno G, Pintucci JP. N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review. Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2942-8. PMID: 25339490.
-Kalyuzhin OV. Effect of N-acetylcysteine on mucosal immunity of respiratory tract. Ter Arkh. 2018 Apr 19;90(3):89-95. doi: 10.26442/terarkh201890389-95. PMID: 30701862.
-De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J. 1997 Jul;10(7):1535-41. doi: 10.1183/09031936.97.10071535. PMID: 9230243.
-Lee SI, Kang KS. N-acetylcysteine modulates lipopolysaccharide-induced intestinal dysfunction. Sci Rep. 2019 Jan 30;9(1):1004. doi: 10.1038/s41598-018-37296-x. PMID: 30700808; PMCID: PMC6353963.
-Mottahedin A, Blondel S, Ek J, Leverin AL, Svedin P, Hagberg H, Mallard C, Ghersi-Egea JF, Strazielle N. N-acetylcysteine inhibits bacterial lipopeptide-mediated neutrophil transmigration through the choroid plexus in the developing brain. Acta Neuropathol Commun. 2020 Jan 23;8(1):4. doi: 10.1186/s40478-019-0877-1. PMID: 31973769; PMCID: PMC6979079.
-Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901. PMID: 18990082.
-Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther. 2014 Feb;141(2):150-9. doi: 10.1016/j.pharmthera.2013.09.006. Epub 2013 Sep 28. PMID: 24080471.
-Corcoran GB, Wong BK. Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl-D-cysteine in mice. J Pharmacol Exp Ther. 1986 Jul;238(1):54-61. PMID: 3723405.
-Dilger RN, Baker DH. Oral N-acetyl-L-cysteine is a safe and effective precursor of cysteine. J Anim Sci. 2007 Jul;85(7):1712-8. doi: 10.2527/jas.2006-835. Epub 2007 Mar 19. PMID: 17371789.
-Eroglu N, Erduran E, Reis GP, Bahadır A. Therapeutic effect of N-acetylcysteine on chemotherapy-induced liver injury. Ir J Med Sci. 2020 Nov;189(4):1189-1194. doi: 10.1007/s11845-020-02219-1. Epub 2020 Apr 1. PMID: 32239424.
-de Andrade KQ, Moura FA, dos Santos JM, de Araújo OR, de Farias Santos JC, Goulart MO. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. Int J Mol Sci. 2015 Dec 18;16(12):30269-308. doi: 10.3390/ijms161226225. PMID: 26694382; PMCID: PMC4691167.
02. Quercétine
-Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y. Quercetin, Inflammation and Immunity. Nutrients. 2016 Mar 15;8(3):167. doi: 10.3390/nu8030167. PMID: 26999194; PMCID: PMC4808895.
Marunaka Y, Marunaka R, Sun H, Yamamoto T, Kanamura N, Inui T, Taruno A. Actions of Quercetin, a Polyphenol, on Blood Pressure. Molecules. 2017 Jan 29;22(2):209. doi: 10.3390/molecules22020209. PMID: 28146071; PMCID: PMC6155806.
-Andres S, Pevny S, Ziegenhagen R, Bakhiya N, Schäfer B, Hirsch-Ernst KI, Lampen A. Safety Aspects of the Use of Quercetin as a Dietary Supplement. Mol Nutr Food Res. 2018 Jan;62(1). doi: 10.1002/mnfr.201700447. Epub 2017 Dec 19. PMID: 29127724.
-Patel RV, Mistry BM, Shinde SK, Syed R, Singh V, Shin HS. Therapeutic potential of quercetin as a cardiovascular agent. Eur J Med Chem. 2018 Jul 15;155:889-904. doi: 10.1016/j.ejmech.2018.06.053. Epub 2018 Jun 27. PMID: 29966915.
-Carullo G, Cappello AR, Frattaruolo L, Badolato M, Armentano B, Aiello F. Quercetin and derivatives: useful tools in inflammation and pain management. Future Med Chem. 2017 Jan;9(1):79-93. doi: 10.4155/fmc-2016-0186. Epub 2016 Dec 20. PMID: 27995808.
-Babaei F, Mirzababaei M, Nassiri-Asl M. Quercetin in Food: Possible Mechanisms of Its Effect on Memory. J Food Sci. 2018 Sep;83(9):2280-2287. doi: 10.1111/1750-3841.14317. Epub 2018 Aug 13. PMID: 30103275.
03. Vitamine D
-Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013 Jul 5;5(7):2502-21. doi: 10.3390/nu5072502. PMID: 23857223; PMCID: PMC3738984.
-Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Griffiths CJ, Janssens W, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S Jr, Stelmach I, Kumar GT, Urashima M, Camargo CA Jr. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017 Feb 15;356:i6583. doi: 10.1136/bmj.i6583. PMID: 28202713; PMCID: PMC5310969.
-Kim D. The Role of Vitamin D in Thyroid Diseases. Int J Mol Sci. 2017 Sep 12;18(9):1949. doi: 10.3390/ijms18091949. PMID: 28895880; PMCID: PMC5618598.
Cantorna MT, McDaniel K, Bora S, Chen J, James J. Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med (Maywood). 2014 Nov;239(11):1524-30. doi: 10.1177/1535370214523890. Epub 2014 Mar 25. PMID: 24668555; PMCID: PMC4176535.
04. Vitamine A
Riccio P, Rossano R. Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis. Neurotherapeutics. 2018 Jan;15(1):75-91. doi: 10.1007/s13311-017-0581-4. PMID: 29067566; PMCID: PMC5794694.
Brown CC, Noelle RJ. Seeing through the dark: New insights into the immune regulatory functions of vitamin A. Eur J Immunol. 2015 May;45(5):1287-95. doi: 10.1002/eji.201344398. PMID: 25808452; PMCID: PMC4426035.
Patel S, Vajdy M. Induction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoids. Expert Opin Biol Ther. 2015;15(10):1411-28. doi: 10.1517/14712598.2015.1066331. Epub 2015 Jul 17. PMID: 26185959; PMCID: PMC4832596.
English version
(following an injection of gene substances)
The numbers in brackets correspond to studies that you will find at the end of the article.
If you know other studies, you can leave a detailed message at the bottom of the page.
1.take before and after the injection
-At least 3 days before the injection, take activated charcoal
(3 per day 2 hours before or after any other medication)
and do not take it the same day.
-NAC (N-Acetyl-L-Cysteine) or liposomal glutathione (continuous) (01)
-Quercetin (continuous) (02)
-Vitamin D (continuous) + cod liver (03)
-Vitamin K2 (continuous)
-Vitamin A (continuous) (04)
-Vitamin C (continuous) (if not present with NAC) (05)
(continuous)
-Vitamin E (continuous) (06)
-Selenium (continuous)
-Zinc (continuous) + oysters and seafood
Gemmotherapy:
-Rosemary, Rosmarinus officinal hepato-protective (3 weeks, stop for a week then resume)
-Juniper, Juniperus communis kidney and liver detoxification (heavy metals) (3 weeks, then wait 3 months before resuming)
- Scots pine, Pinus sylvestris general detoxification, immune and respiratory protection (3 weeks, stop for one week then resume)
-Lilac, Syringa vulgaris (3 weeks, stop for a week then resume)
2.Elimination through kidneys and liver
Artichoke,
Black radish,
Lemon, olive oil,
Milk thistle,
Desmodium,
Dandelion (leaves)
Hibiscus (leaves)
Chlorella pyrenoidosa
Activated carbon (for 1 week)
Parsley (juice, herbal teas, decoctions)
Grenade
Cress
Rosemary
Horsetail
Betaine
Alpha lipoic acid
Magnesium citrate
Potassium citrate
4. Blood
-Quercetin + Bromelain (improves the absorption of quercetin) (between 10 and 200mg / day taken regularly and 1000mg over a short period)
Organic quercetin:
-Capres, Red onions
Bibliographical references
01. N-Acétyl-L-Cystéine
-De Flora S, Balansky R, La Maestra S. Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19. FASEB J. 2020 Oct;34(10):13185-13193. doi: 10.1096/fj.202001807. Epub 2020 Aug 11. PMID: 32780893; PMCID: PMC7436914.
-Poe FL, Corn J. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2. Med Hypotheses. 2020 Oct;143:109862. doi: 10.1016/j.mehy.2020.109862. Epub 2020 May 30. PMID: 32504923; PMCID: PMC7261085.
-Dinicola S, De Grazia S, Carlomagno G, Pintucci JP. N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review. Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2942-8. PMID: 25339490.
-Kalyuzhin OV. Effect of N-acetylcysteine on mucosal immunity of respiratory tract. Ter Arkh. 2018 Apr 19;90(3):89-95. doi: 10.26442/terarkh201890389-95. PMID: 30701862.
-De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J. 1997 Jul;10(7):1535-41. doi: 10.1183/09031936.97.10071535. PMID: 9230243.
-Lee SI, Kang KS. N-acetylcysteine modulates lipopolysaccharide-induced intestinal dysfunction. Sci Rep. 2019 Jan 30;9(1):1004. doi: 10.1038/s41598-018-37296-x. PMID: 30700808; PMCID: PMC6353963.
-Mottahedin A, Blondel S, Ek J, Leverin AL, Svedin P, Hagberg H, Mallard C, Ghersi-Egea JF, Strazielle N. N-acetylcysteine inhibits bacterial lipopeptide-mediated neutrophil transmigration through the choroid plexus in the developing brain. Acta Neuropathol Commun. 2020 Jan 23;8(1):4. doi: 10.1186/s40478-019-0877-1. PMID: 31973769; PMCID: PMC6979079.
-Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901. PMID: 18990082.
-Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther. 2014 Feb;141(2):150-9. doi: 10.1016/j.pharmthera.2013.09.006. Epub 2013 Sep 28. PMID: 24080471.
-Corcoran GB, Wong BK. Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl-D-cysteine in mice. J Pharmacol Exp Ther. 1986 Jul;238(1):54-61. PMID: 3723405.
-Dilger RN, Baker DH. Oral N-acetyl-L-cysteine is a safe and effective precursor of cysteine. J Anim Sci. 2007 Jul;85(7):1712-8. doi: 10.2527/jas.2006-835. Epub 2007 Mar 19. PMID: 17371789.
-Eroglu N, Erduran E, Reis GP, Bahadır A. Therapeutic effect of N-acetylcysteine on chemotherapy-induced liver injury. Ir J Med Sci. 2020 Nov;189(4):1189-1194. doi: 10.1007/s11845-020-02219-1. Epub 2020 Apr 1. PMID: 32239424.
-de Andrade KQ, Moura FA, dos Santos JM, de Araújo OR, de Farias Santos JC, Goulart MO. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. Int J Mol Sci. 2015 Dec 18;16(12):30269-308. doi: 10.3390/ijms161226225. PMID: 26694382; PMCID: PMC4691167.
02. Quercétine
-Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y. Quercetin, Inflammation and Immunity. Nutrients. 2016 Mar 15;8(3):167. doi: 10.3390/nu8030167. PMID: 26999194; PMCID: PMC4808895.
-Marunaka Y, Marunaka R, Sun H, Yamamoto T, Kanamura N, Inui T, Taruno A. Actions of Quercetin, a Polyphenol, on Blood Pressure. Molecules. 2017 Jan 29;22(2):209. doi: 10.3390/molecules22020209. PMID: 28146071; PMCID: PMC6155806.
-Andres S, Pevny S, Ziegenhagen R, Bakhiya N, Schäfer B, Hirsch-Ernst KI, Lampen A. Safety Aspects of the Use of Quercetin as a Dietary Supplement. Mol Nutr Food Res. 2018 Jan;62(1). doi: 10.1002/mnfr.201700447. Epub 2017 Dec 19. PMID: 29127724.
-Patel RV, Mistry BM, Shinde SK, Syed R, Singh V, Shin HS. Therapeutic potential of quercetin as a cardiovascular agent. Eur J Med Chem. 2018 Jul 15;155:889-904. doi: 10.1016/j.ejmech.2018.06.053. Epub 2018 Jun 27. PMID: 29966915.
-Carullo G, Cappello AR, Frattaruolo L, Badolato M, Armentano B, Aiello F. Quercetin and derivatives: useful tools in inflammation and pain management. Future Med Chem. 2017 Jan;9(1):79-93. doi: 10.4155/fmc-2016-0186. Epub 2016 Dec 20. PMID: 27995808.
-Babaei F, Mirzababaei M, Nassiri-Asl M. Quercetin in Food: Possible Mechanisms of Its Effect on Memory. J Food Sci. 2018 Sep;83(9):2280-2287. doi: 10.1111/1750-3841.14317. Epub 2018 Aug 13. PMID: 30103275.
03. Vitamine D
-Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013 Jul 5;5(7):2502-21. doi: 10.3390/nu5072502. PMID: 23857223; PMCID: PMC3738984.
-Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Griffiths CJ, Janssens W, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S Jr, Stelmach I, Kumar GT, Urashima M, Camargo CA Jr. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017 Feb 15;356:i6583. doi: 10.1136/bmj.i6583. PMID: 28202713; PMCID: PMC5310969.
-Kim D. The Role of Vitamin D in Thyroid Diseases. Int J Mol Sci. 2017 Sep 12;18(9):1949. doi: 10.3390/ijms18091949. PMID: 28895880; PMCID: PMC5618598.
Cantorna MT, McDaniel K, Bora S, Chen J, James J. Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med (Maywood). 2014 Nov;239(11):1524-30. doi: 10.1177/1535370214523890. Epub 2014 Mar 25. PMID: 24668555; PMCID: PMC4176535.
04. Vitamine A
Riccio P, Rossano R. Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis. Neurotherapeutics. 2018 Jan;15(1):75-91. doi: 10.1007/s13311-017-0581-4. PMID: 29067566; PMCID: PMC5794694.
Brown CC, Noelle RJ. Seeing through the dark: New insights into the immune regulatory functions of vitamin A. Eur J Immunol. 2015 May;45(5):1287-95. doi: 10.1002/eji.201344398. PMID: 25808452; PMCID: PMC4426035.
Patel S, Vajdy M. Induction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoids. Expert Opin Biol Ther. 2015;15(10):1411-28. doi: 10.1517/14712598.2015.1066331. Epub 2015 Jul 17. PMID: 26185959; PMCID: PMC4832596.